SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-4/A - Registration of securities, business combinations: [Amend]
SEC Accession No. 0001193125-22-085303
Filing Date
2022-03-25
Accepted
2022-03-25 17:17:02
Documents
9

Document Format Files

Seq Description Document Type Size
1 S-4/A d299220ds4a.htm S-4/A 4152523
2 EX-23.1 d299220dex231.htm EX-23.1 1432
3 EX-23.2 d299220dex232.htm EX-23.2 1695
4 EX-FILING FEES d299220dexfilingfees.htm EX-FILING FEES 33004
5 GRAPHIC g299220g03a10.jpg GRAPHIC 51990
6 GRAPHIC g299220g03b10.jpg GRAPHIC 48494
7 GRAPHIC g299220g39h88.jpg GRAPHIC 227262
8 GRAPHIC g299220g55v68.jpg GRAPHIC 112370
9 GRAPHIC g299220g89h35.jpg GRAPHIC 81551
  Complete submission text file 0001193125-22-085303.txt   4882849
Mailing Address 12 GILL STREET SUITE 4650 WOBURN MA 01801
Business Address 12 GILL STREET SUITE 4650 WOBURN MA 01801 617.871.2101 EXT 313
Comera Life Sciences Holdings, Inc. (Filer) CIK: 0001907685 (see all company filings)

IRS No.: 000000000
Type: S-4/A | Act: 33 | File No.: 333-263377 | Film No.: 22772412
SIC: 2834 Pharmaceutical Preparations